case_images: PMC9120773_01
case_images: Bronchoscopy liquid-based cytology showed Aspergillus.
case_images: fonc-12-824393-g001.jpg
case_images: PMC9120773_01_fonc-12-824393-g001.jpg
case_images: f1
case_images: The lung fiber bronchoscopy showed abnormal echogenic lesions in the right lower lung basal segment, and bronchoscopy liquid-based cytology showed Aspergillus ( Figure 1 ).
case_images: CT-scan of the lungs in the early stage of disease (A), after treatment (B-D), review after one month (E), and review after three months (F).
case_images: fonc-12-824393-g002.jpg
case_images: PMC9120773_01_fonc-12-824393-g002.jpg
case_images: f2
case_images: Blood routine showed that WBCs were 0.63x10^9/L, and lung CT showed a mass in the right lower lung ( Figure 2 ). When the lung CT on April 8 showed further improvement ( Figure 2 ), Cladribine was administrated at 0.14mg/Kg/day daily for 5 days.
case_images: The flow phenotype of the blood cells presented as two-dimensional graphs.
case_images: fonc-12-824393-g003.jpg
case_images: PMC9120773_01_fonc-12-824393-g003.jpg
case_images: f3
case_images: T cells (0.8%) ( Figure 3 ). TCR test showed positive gammadelta rearrangement, and metagenomic next-generation sequencing (mNGS) detected Aspergillus.
case_images: Large granular lymphocytes in bone marrow cytology smear.
case_images: fonc-12-824393-g004.jpg
case_images: PMC9120773_01_fonc-12-824393-g004.jpg
case_images: f4
case_images: The results of the bone marrow smear showed active bone marrow hyperplasia with increased erythrocyte colonies and decreased lymphocyte colonies compared to those of the last time ( Figure 4 ).
case_images: Fusion gene NPL-DHX9 rearrangement through an RNA-sequencing analysis.
case_images: fonc-12-824393-g005.jpg
case_images: PMC9120773_01_fonc-12-824393-g005.jpg
case_images: f5
case_images: The signal transducer and activator of the transcription-3 (STAT3) Y640F mutation and fusion gene NPL-DHX9 rearrangement were confirmed by RNA-sequencing analysis ( Figure 5 ). The patient was diagnosed with gamma/delta variant T-cell LGL leukemia (NPL-DHX9 positive) on March 22.
case_images: Timeline of disease and treatment periods.
case_images: fonc-12-824393-g006.jpg
case_images: PMC9120773_01_fonc-12-824393-g006.jpg
case_images: f6
case_images: The timeline of the disease and treatments are shown in  Figure 6 .